Phase 2 Readout
SYRE: Phase 2 Readout: spy002
December 31, 2026 · spy002. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Spyre Therapeutics, Inc. (SYRE)
- Drug
- spy002
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: spy002
- Drug
- spy002
- Indication
- active ulcerative colitis